Search Results 3461-3470 of 17044 for pharmacogenetics
Staff at the Alzheimer's Disease Research Center at Mayo Clinic Florida are reaching out to communities underrepresented in healthcare to attract more people to ...
The purpose of this study is to evaluate the effectiveness and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of ...
Cortez GM, Monteiro A, Ludwig B, Hanel R. Reappraisal of haemorrhagic suprasellar pilocytic astrocytoma during adulthood. BMJ Case Rep. 2020 Oct 29; 13 (10)
Mayo Clinic Q&A podcast: COVID-19 trials pause over safety concerns featured image · Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ ...
Changes in how brain cells generate energy may drive the development of Alzheimer's disease and influence how patients respond to therapy, according to a new[..
About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...
Marla Broadfoot, Ph.D. March 4, 2026. Mayo Clinic researchers identify key DNA changes in the brains of people with Alzheimer's disease featured.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
JACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year[...] ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!